EFFECT OF THE CONCOMITANT USE OF SPIRONOLACTONE AND LOOP DIURETICS ON THE CLINICAL OUTCOME IN PATIENTS WITH NYHA CLASS 1 OR 2 CHRONIC HEART FAILURE

EFFECT OF THE CONCOMITANT USE OF SPIRONOLACTONE AND LOOP DIURETICS ON THE CLINICAL OUTCOME IN PATIENTS WITH NYHA CLASS 1 OR 2 CHRONIC HEART FAILURE

Background Aldosterone receptor antagonists (ARA) classified as potassium sparing diuretics is administered concomitantly with loop diuretics for the management of patients with chronic heart failure (CHF) in usual clinical setting.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2012-03, Vol.59 (13), p.E883-E883
Hauptverfasser: Iwasaki, Yusuke, Yamada, Takahisa, Morita, Takashi, Furukawa, Yoshio, Tanaka, Koji, Kawasaki, Masato, Kuramoto, Yuki, Fujimoto, Tadao, Ozu, Kentaro, kondo, takumi, Sengoku, Kaoruko, Yamamoto, Hironori, Fukunami, Masatake
Format: Artikel
Sprache:eng
Schlagworte:
Cardiology
Cardiovascular
Clinical outcomes
Diuretics
Drug therapy
Heart failure
Internal Medicine
Potassium
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background Aldosterone receptor antagonists (ARA) classified as potassium sparing diuretics is administered concomitantly with loop diuretics for the management of patients with chronic heart failure (CHF) in usual clinical setting.
ISSN:0735-1097
1558-3597
DOI:10.1016/S0735-1097(12)60884-5